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            Abstract 
Background: Infection by HPV oncogenic subtypes is the causative agent of 
half a million cancer cases in developed countries every year. The objective of the 
present study was to assess: a. the knowledge and beliefs of young Greeks about HPV 
infection and b. potential factors that discourage them from HPV vaccination.  
Methods: Our group consisted of 825 individuals, 18-35 years old, who 
voluntarily completed some questionnaires. 
Results: The attitude and consequent decision of women, considering HPV 
vaccination is associated with general vaccination attitude, mothers’ beliefs, parents’ 
educational level, family income, knowledge about HPV, the doctor's attitude and 
individual’s health beliefs.  
            Conclusion: In Greece, as well as in other countries where HPV vaccination is 
neither a mandatory nor a school-based program, increased education of physicians and 
parents would substantially enhance HPV vaccination acceptance. Intervention 
strategies should focus more on providing adequate and reliable information to 
eliminate any doubts on HPV vaccine’s safety and efficacy. 
 
 
Introduction 
Cervical cancer is a rare complication of a very frequent infection since more 
than 80% of sexually active women and men will be infected by Human Papilloma 
Virus (HPV) in their lifetime. The HPV persistent infection by oncogenic subtypes is 
the starting point of carcinogenesis for cancers of the lower genital tract (especially the 
cervix of the womb) (1) and “other-than-cervical” cancers (increasing trend of anal and 
oropharyngeal HPV-related malignancies in younger individuals) (2). 
 More than 200 million doses of the anti HPV vaccine have been administered 
since 2006 but despite the cumulative evidence of safety and efficacy (3), the 
vaccination coverage remains low. Specifically in Europe, coverage is significantly 
heterogeneous. Northern Europe reports show 69% coverage in the group of 15-19 
years old, while in Eastern Europe there is just 8% vaccination coverage in the same 
age group (4). 
In Greece, a publicly funded national HPV vaccination program has been 
implemented and since 2008 the vaccine has been available for the target population – 
girls aged 11-15 years old and teens until the age of 18 – while women aged 18-26 had 
the opportunity of free catch-up-vaccination until 31/12/2016. Despite the cost-free 
vaccine availability and the unanimous acceptance by the relevant scientific 
committees, the coverage does not exceed the 44.3% of the target population in any 
report (5, 6).  
Several explanatory models have been designed aiming to understand the 
factors that shape health habits or factors that contribute to the adoption of preventive 
or health promotion behaviors and most of them agree that the way in which an 
individual perceives a situation will determine his/her final behavior (7). One of the 
most commonly applied models is the Health Belief Model (HBM), developed by 
Becker in 1974, according to which the probability for an individual to amend a 
personal health behavior depends on whether he/she: a) believes that there is a high 
possibility of being infected by a disease (perceived susceptibility), b) believes that a 
condition can have a serious impact on one’s health with serious consequences 
(perceived severity), c) believes that the proposed medical practices, interventions or 
behaviors can reduce the risk or the impact on one’s health (perceived benefit), d) 
believes that there are negative consequences (financial cost, psychological distress, 
side effects) related to the proposed change of behavior (perceived barriers).   
 
 
 
 
 
 
 
 
 
 
 
 
Methods 
 Our cohort consisted of 825 young adults, aged between 18-35 years old, who 
completed a questionnaire which was distributed in 2016 in an electronic form by social 
media. Only a single questionnaire could be submitted from each IP address and the 
process was fully anonymised. Sociodemographic data were collected, as well as data 
about sexual behavior and lifestyle factors considered as risk factors for cervical cancer 
(namely: age of first sexual contact, number of sexual partners, Pap smear results, 
smoking and condom use). For the data collection the following questionnaires were 
used:  
1. HPV Knowledge Scale  
HPV-Knowledge Scale (HPV-KS) (8) was developed as a valid framework for 
assessing knowledge regarding HPV (9). The short form was used in the present study 
which includes 10 items (true or false type) with the total knowledge score ranging 
from 0 to10 (1 point given to the correct answer and 0 to the false answer).  
2. Health Belief Model Scale for HPV and Vaccination (HBMS-HPVV)  
The HBM questionnaire was translated and adapted in Greek from Kim’s scale and 
a relevant study in Turkish students (8, 9). The final version of the scale includes 14 
statements corresponding to: perceived benefits (items 1-3), perceived susceptibility 
(items 4 and 5), perceived severity (items 6-9) and perceived barriers (items 10-13 and 
14). The answers were given by a 4-item Likert- type scale, from 1 (“not at all”) to 4 
(“very much”) to assess the extent to which the participants agree with each statement. 
3. Control Preference Scale (CPS):  
The Control Preference Scale (CPS) was developed by Degner et al. (1997) 
aiming to assess the extent to which an individual wishes to take control over decisions 
and it was integrated in the current study because it is well known that this preference 
affects the final attitude and behavior towards health issues. The scale has been 
validated and used in several patient groups in literature (Sung et al. 2010), it consists 
of a question with five possible answers (range from 1 to 5) and the participants can be 
assigned into three categories as preferring: a. an active role (“I prefer to make the final 
decision” or “I prefer to make the final decision after seriously considering my doctor's 
opinion”), b. a collaborative role (“I prefer that my doctor and I share responsibility 
for the decision” c. a passive role (I prefer that my doctor makes the decision after 
he/she seriously considers my opinion” or “ I prefer my doctor to make the decision”).  
The three instruments were translated from English to Greek using the method of 
forward–backward translation by three independent translators and the draft version 
was tested by personal interview in 10 participants. The literary editing and the 
translation of medical terms in an understandable way were made by three bilingual 
health professionals (2 gynaecologists and 1 psychologist). 
Ethical considerations 
Permission was granted for the use of the HPV Knowledge Scale (HKS) and 
Health Belief Model Scale for HPV and Vaccination (HBMS-HPVV) after contacting 
Professor Kim. Only answers from participants older than 18 were used for analysis, 
which is the legal age of consent, since HPV is a sexually transmitted virus. The 
questionnaire was anonymised and participants were informed that they could return 
the completed questionnaire only in case they were consenting to the use of the 
provided data for analysis. 
Statistical analysis 
For the statistical analysis the method of frequency analysis was employed in 
addition to the Cross Tabs analysis and the x2 (Chisquare) test which were also used for 
the one-to-one comparative analysis. The specific analysis can lead to the identification 
of differences between the frequencies of co-occurrence of the values of two different 
variables. The level of significance was defined as p< 0.05, the independent variables 
were the attitude towards HPV vaccination and the received vaccination, and the 
dependent variables were all the questions regarding level of knowledge, beliefs and 
attitudes regarding HPV infection and vaccination.  
For further analysis, the non-parametric Kruskal-Wallis (KW)/ Mann-Whitney 
(MW) tests were used: 1) for studying whether the attitude towards HPV vaccination 
was significantly related to the 4 components of the HBM model (susceptibility, 
severity, benefit and barriers) – KW and 2) for studying whether the total HPV 
knowledge score of each participant was statistically related to the 4 HBM components 
- KW.  
At last, the Spearman's rank-order correlation test was used for searching 
whether the total knowledge score of each participant was correlated to the education 
level (individual level, mother’s, father’s level). All analyses were performed using the 
Statistical Package for the Social Sciences (SPSS) version 21.0 (SPSS Inc., Chicago, 
IL, USA) for Windows. 
 
Results 
Sociodemographic characteristics 
The participant’s ages ranged from 18 to 35 years old (mean, 23.67; SD, 3.97), 
669 were females (81.1%) and 156 males (18.9%). Regarding marital status, the vast 
majority (93.3%) were singles, while with respect to the educational level the majority 
(94.7%) were students or graduates of higher technological institutes or universities 
(37.5% studying or having studied at the field of health sciences and 22.8% at human 
sciences). 
Sexual behavior -Lifestyle factors 
The age of first sexual contact was between 15-18 years old for 38.2% and 18-
23 years old for 48.1% of the participants. Estimating other risk factors, 72% were using 
condom regularly and 61.7% were nonsmokers. Furthermore, 71.4% of the women had 
attended at least once a cervical screening examination/smear (table I). 
Attitude towards vaccination 
For vaccines in general, 47.1% of the participants were positive towards all 
approved vaccines, 49.6% were ambivalent (their attitude depended on different 
vaccines) and only 3.3% were negative against all vaccines. However, specifically for 
the HPV vaccine, 89.8% were aware of its existence, 81.5% had a positive opinion for 
HPV vaccine, but only 51% had been vaccinated. 
Among the vaccinated women, 44.1% had undergone HPV vaccination at the 
ideal period (before sexual life onset) and the main two reasons for being positive to 
the HPV vaccine were the declarations that “vaccination is the best method of 
prevention” (68.8%) and the “fear of disease” (11.1%). Conversely, the main two 
reasons for being opposed to the vaccine were the “fear of possible side effects” (55.3%) 
and the “insufficient scientific justification” (29.5%). 
Knowledge about HPV 
The mean score in the HPV Knowledge Scale was 5.38 for women (range 2-9) 
and 5.43 for men (range 2-8) of a possible 10 (Table II). The sample (both women and 
men) had good knowledge about the facts that: 1) “some HPV subtypes causing warts 
of male and female genitalia”, 2) “HPV is sexually transmitted”, and 3) “HPV vaccine 
can prevent infection from certain HPV types”. On the other hand, participants had poor 
knowledge about that: 1) “HPV in not a low risk virus and can cause cancer”, 2) 
“sexually active women should not attend an annual HPV examination”.   
The analysis did not find any correlation between the Total Knowledge and the 
participants’ educational level (p=0.092) or mothers’ (p=0.216) and fathers’ (p=0.313) 
educational level. 
Factors related to women’s attitude towards vaccination  
Due to the fact that in Greece, the free vaccination program covered only girls 
and women up to 26 years old (until December 2016) and not boys / men, but also due 
to the small percentage of men (N=156, 18.9%) who participated in the present study 
the correlation tests included only the women’s subgroup. 
Table III presents the results of the correlation analyses performed to assess the 
associations of Non-HBM factors with the women’s attitude towards vaccination. As 
shown, the attitude towards vaccination was positively associated with general attitude 
towards vaccines (p=0.000), mother’s education (p=0.026), mother’s attitude towards 
HPV vaccination (p=0.000), doctor’s attitude (p=0.000), as well as with the hypothesis 
(for the Greek population) of having to pay for HPV vaccination (p=0.000).  
Furthermore, positive association was noted with two items of the HPV-
Knowledge Scale: the knowledge that the HPV is being related to cervical cancer 
(p=0.007) and that it is a sexually transmitted infection (p=0.007). 
Regarding the HBM factors (table IV), it was found that the positive attitude 
towards HPV vaccination was positively correlated with susceptibility (p=0.000) and 
benefits (p=0.000) and negatively correlated with barriers (p=0.000) (“I have difficulty 
deciding at an early age for HPV vaccination”, “I doubt the safety and efficacy of the 
vaccine”, “Possible side effects of HPV vaccination make me worry”). However, the 
analysis revealed no correlation between the attitude towards HPV vaccination and 
severity (p=0.090) (“HPV infection is a serious disease that can disturb everyday life”, 
“HPV infection would threaten a relationship with my boyfriend, husband or partner”, 
“The thought of HPV infection scares me”).  
 
Factors related to received vaccination  
Correlation analyses were performed in women who had been vaccinated 
(N=358) to assess the associations between the Non-HBM factors and the fact of 
vaccination. Positive associations were found with participants’ educational level 
(p=0.028), general attitude towards vaccines (p=0.000), both parents’ educational level 
(for mothers p=0.004 and for fathers p=0.000), mothers’ attitude (p=0.000), family 
income (p=0.011), doctors’ attitude (p=0.000), cervical screening program compliance 
(p=0.000) and satisfaction from the provided information (p=0.000). 
From the 10 items of the HPV Knowledge Scale, only 4 correct answers 
exhibited statistically significant correlation with the participants’ vaccination status. 
Those who self-reported as vaccinated were more likely to answer correctly that “HPV 
is related to cervical cancer” (p=0.007), “HPV is a sexually transmitted virus” 
(p=0.007) and that “HPV can infect the oral cavity, respiratory tract, and eyes” 
(p=0.012). In addition, the vaccinated participants falsely answered that “Sexually 
active women should undergo an HPV examination annually” (p=0.008). 
On the other hand, the received vaccination was negatively associated with the 
belief from HBMS-HPVV that “HPV vaccination increases sexual curiosity or causes 
earlier exposure to sexual intercourse” (perceived barriers, p=0.011). 
Control Preference Scale  
At last regarding the Control Preference Scale analysis, 74.1% of the 
participants prefer the active role in decision making, 20.1% take the decision about 
medical issues together with their doctor (collaborative role) and only 4.7% prefers to 
have a passive role leaving the decision to the doctor (Table 4). 
Specifically for HPV vaccination, for 22.4% of the participants the decision for 
vaccination was taken in cooperation with the physician, for 20% the decision was 
taken by the participant’s mother alone, for 33.9% it was a common decision of the 
individuals and their mothers and a smaller proportion of 19.2% took the decision for 
HPV vaccination by themselves (active role).  
 
 
 
Discussion 
The vaccination coverage was 51% which is higher than the 11% to 44.3% 
which has been previously reported in Greece (5, 6). However, this was yet lower than 
the 63% in the USA (10) and lower than the threshold of 70% that is the lowest 
acceptable coverage rate at which vaccination policy is cost effective (11). Likewise, 
71.4% attended at least once the cervical cancer screening program and this was in 
accordance with the highest Greek reported estimate of cervical cancer screening 
compliance – 79% (12). Hence, the sample of the present study can be considered to be 
of high performance, regarding cervical cancer prevention attitudes. 
General vaccination attitude 
According to previously documented data, the belief in “protection of licensed 
vaccines in general” was correlated to HPV vaccine acceptability (13) and this was in 
line with the current study’s results in which the “General attitude towards vaccination” 
was significantly associated with “HPV vaccination acceptance”. Apart from that, it 
has been reported that HPV vaccine, influenza and MMR vaccines appear as the top 
three vaccines with the lowest acceptance (14) and because of this fact further analysis 
is required. 
Health beliefs about HPV vaccination 
Regarding HBMS-HPVV results, it was observed that women who had positive 
attitude toward vaccination showed higher perceived susceptibility and perceived 
benefits, in accordance with other studies (9, 17, 18, and 19). These findings show that 
women who: a) consider themselves at high risk regarding HPV infection and b) 
appreciate the importance of the HPV vaccine benefits, tend to adopt a positive attitude 
towards vaccination. However, perceived severity (belief on potential serious impact of 
HPV infection on one’s health with serious consequences) did not appear to be an 
influencing factor towards vaccination, in contrast to other studies (17) which reported 
a correlation between perceived severity and the intention vaccination. In other words 
it is more a matter of convincing the Greek population on vaccination benefits rather 
than disseminating fear about HPV infection (perceived severity) and one could expect 
that the arrival of the 9-valent vaccine might increase uptake, since it is designed to 
provide wider type-coverage and protection (additional vaccination benefit). 
At last the negative attitude towards HPV vaccination was associated with the 
factor perceived barriers of the ΗΒΜS-HPVV. This finding confirms that the 
reluctance to HPV vaccination is due to fear of adverse effects and doubt on efficacy 
(20). 
Knowledge and vaccination 
Positive correlations were observed between “having received vaccine” and 
knowledge facts. Specifically in the Greek population the knowledge facts which could 
boost vaccination acceptance were: 1) “HPV is sexually transmitted”, 2) “HPV vaccine 
can prevent HPV-related cancers and warts” and 3) “HPV vaccine can prevent infection 
from certain HPV types”. 
In other relevant studies, high knowledge scores have been correlated with HPV 
vaccination intention (21, 9) increased vaccination rates at follow up (22) and in a Greek 
population has been associated with high vaccine uptake (23). All these studies support 
that there is a direct association between knowledge and intended behavior – 
vaccination.  
Although that knowledge is considered as an important factor favoring 
vaccination, it has to be noted that in the present study it is not the total knowledge on 
HPV that leads to increased vaccination acceptance (Total Knowledge Score did not 
show any correlation with attitude towards vaccination), but the knowledge of specific 
facts which could be probably varying between different societies.  
The role of parents 
In the Greek society as shown on the results, mothers’ beliefs are crucial for 
HPV vaccination decision, whereas studies from other societies report both parents’ 
beliefs to be important and irrelevant to racial group differences (24).  
HPV vaccination acceptance was also significantly associated with mothers’ 
educational level and the performed vaccination was significantly associated with 
fathers’ educational level. Similarly, mother’s education was positively correlated to 
vaccination in a USA cohort (25) and in studies from Austria and Sweden (26, 27). 
However, in societies such as the UK, the parental educational level has not been 
correlated to HPV vaccine acceptance (28, 29).  
Furthermore, the present findings underlined that having to make the decision 
for vaccination at an early age was an important barrier and this is a fact which probably 
enhances the role of parents in decision making. 
Physicians’ role  
Likewise, the role of physicians is of paramount importance for HPV 
vaccination in Greece. Similarly to other studies it was highlighted that doctor’s strong 
recommendation - encouragement were essential components for HPV vaccine 
acceptance (24, 19, 30, 31).  
Hence, it is worrying that 26.5% of the Greek doctors (according to participants’ 
answers) were ambivalent regarding HPV vaccination. It was only 71.1% of doctors 
who were strongly recommending vaccination and even worse a small minority tended 
to discourage patients from vaccination (2.4%). This is in discordance with the results 
of other studies which have recently reported that 7% of doctors were ambivalent about 
risk/benefit of the specific vaccine in the USA (14).  
For further understanding of the doctors’ influence, it is important to emphasize 
results of the Control Preference Scale, because autonomy in decision making for 
medical issues varies between different cultures and ethnicities (15).  Taking into 
account the findings from the present study, it is confirmed that the factor “physician’s 
recommendation” is a key in HPV vaccination decision, as shown in other studies (16). 
Specifically the results show that 69.2% of the participants seriously considered the 
doctors’ opinion, 20.1% made the decision together with their doctor (collaborative 
model in decision making) and 4.7% left the decision to the doctor thus giving to the 
doctor a primary role in decision making. 
Satisfaction on available information  
 In addition to the above mentioned, doctors (39%) and internet (27%) appeared 
to be the main sources of information on HPV vaccination in the current study. 
Furthermore, a statistically significant correlation was found between the positive 
attitude towards HPV vaccination and the satisfaction from provided information and 
as it has been reported by other authors “the participants who felt to be contented after 
consultation or after receiving HPV-relevant information, appeared to be more likely 
to retain a positive opinion for HPV vaccination”, thus satisfaction from provided 
information appears to be a strong determinant of vaccination initiation (32, 33) To 
achieve the goal of information satisfaction doctor’s believe that supporting material 
such as written leaflets for patients/ parent’s education would be a useful adjunct to 
their consultation (14). As for the role of the internet, more than half of the users 
consider nearly all information provided on health sites to be credible (“Pandora box of 
antivaccination misinformation”) (34) which means that antivaccination 
misinformation is an important barrier against HPV vaccination.  
Vaccination and sexual curiosity  
There is an impression among parents that HPV vaccination would provide a 
false sense of safety which might encourage early or unsafe sexual activity (34) and 
likewise in the present study, a statistically significant positive association was 
observed between non-vaccination and the belief that “HPV vaccination increases 
sexual curiosity or causes earlier exposure to sexual intercourse”. On the other hand, 
there was no difference between vaccinated vs non-vaccinated participants in relation 
to the number of sexual partners, age of first sexual contact, smoking and frequency of 
condom’s use. In addition, the vaccinated subgroup shows a significantly higher 
compliance with cervical cancer screening program (p=0.000). This means that the 
vaccinated subgroup, contrary to the misperception of being negligent, were attending 
cervical screening program at a higher rate than the non-vaccinated and this indicates 
increased sense of prevention awareness and responsible, planned behavior. 
Conclusion 
In conclusion, the results of the present study showed that general attitude 
towards vaccines, knowledge about HPV infection, parents’ educational level and their 
attitude towards HPV vaccination, doctors’ attitude and the individual’s health beliefs 
are factors related to vaccination against HPV. Consequently, it is necessary to provide 
adequate and reliable information not only to young people but also to their parents and 
health professionals in order to increase the positive attitude and the intention to receive 
the vaccine.  
Also, public health education programs should focus on concerns about safety 
issues, as it seemed to be one of the major barriers to vaccination. The results of the 
present study confirm the correlation between health behaviors and beliefs, i.e. the 
clearly defined perceptions of individuals that are acquired early in life by interacting 
specially with parents, school and friends. 
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Table I. Lifestyle factors, sexual behavior and attitude towards vaccination 
 Smoking Percentage ,% (♀ / ♂)  
  Yes 32.0 (30.7 ♀ / 37.6 ♂) 
  No 68.0 (69.3♀ / 62.4 ♂) 
Considering smoking as a risk factor  
  Yes 20.8 (21.5 ♀ / 18 ♂) 
  No 25.0 (25.7 ♀ / 22 ♂) 
  
 
 
 
 
 
  Unknown  54.2 (52.8 ♀  / 60 ♂) 
Age of beginning of sexual life   
  No sexual life  7.4 (6.8 ♀ / 9 ♂) 
  <15 3.9 (3.1 ♀ / 7 ♂) 
  15-18  38.2 (37.7 ♀ / 41.3 ♂) 
  18-23 48.1 (50 ♀ / 41.4 ♂) 
  >23 2.4 (2.4 ♀ / 2 ♂) 
Sexual partners   
  <3 38.4 (40 ♀ / 30.5 ♂) 
  3-5 22.6 (24 ♀ / 17.5 ♂) 
  5-10 19.4 (20 ♀ / 17.5 ♂) 
  10-15 7.4 (7.5 ♀ / 9 ♂) 
  >15 4.5 (4,5 ♀ / 19.5 ♂) 
Systematic use of condom  
  Yes 72 (70 ♀ / 80 ♂) 
  No 28 (30 ♀ / 20 ♂) 
Pap-test screening   
  Yes 71.4 ♀ 
  No 28.6 ♀ 
Attitude towards vaccines   
  Positive 47.1 (46 ♀ / 51.5 ♂) 
  Negative 3.3 (3 ♀ / 4.5 ♂) 
  Depends on the vaccine  49.6 (51 ♀ / 44 ♂) 
Knowledge about HPV vaccine existence  
  Yes  89.8 (97 ♀ / 60 ♂) 
  No 10.2 (3 ♀ / 40 ♂) 
Attitude towards HPV vaccine   
  Positive 81.5 (81% ♀ / 84% ♂) 
  Negative  18.5 (19% ♀ / 16% ♂) 
HPV received vaccination  
  Yes 51% ♀  
  No 49% ♀  
Pre-vaccination Satisfaction from provided 
information   
  Not at all- a little 52.5% ♀  
  Quite – very much 47.5% ♀  
Information Sources   
  Internet 27.0 ♀  
  Media 2.2 ♀ 
  Family 9.2 ♀ 
  Friends 11.7 ♀ 
  School  6.2 ♀ 
  Doctor 39.0 ♀ 
Conferences 4% ♀ 
Table II. HPV Knowledge of the sample 
 
HPV Knowledge Items 
Correct 
Answer 
n (%) 
Incorrect 
Answer 
n (%) 
1. HPV is related to the development of cervical cancer of the  
    uterus (T) 
765 (92.6) 61 (7.4) 
2. HPV is a low-risk virus which does not cause cancer (T) 81 (9.9) 745 (90.1) 
3. HPV is almost asymptomatic (T) 251 (30.5) 575 (69.5) 
4. HPV is a sexually transmitted infection (T) 778 (94.2) 48 (5.8) 
5. HPV can infect the oral cavity, respiratory tract, and eyes (T) 491 (59.4) 335 (40.6) 
6. Condoms prevent HPV infection (F) 190 (23.1) 636 (76.9) 
7. If immunity is strong, HPV might gradually disappear (T) 274 (33.3) 552 (66.7) 
8. Sexually active women should undergo an HPV examination  
    annually (F) 
55 (6.7) 771 (93.3)  
9. Vaccination will prevent certain types of HPV (T) 768 (92.9) 58 (7.1) 
10. Some HPV subtypes can cause the development of warts of  
    the labia, the vagina and the penis (T) 
799 (96.7) 27 (3.3) 
 
  Table III. Correlation analyses of Non-HBM variables with the attitude towards  
                  vaccination (Women, N= 669) 
 
Non –HBM Variables OR (95% CI) P value 
General vaccination attitude .426 .000 
Mother’s educational level .118 .026 
Mother’s attitude towards vaccination .566 .000 
Doctor’s attitude towards vaccination .515 .000 
Cost free vaccination .755 .000 
Paid vaccination  .541 .000 
 
  Table IV. Control Preference Scale 
Control Preference Scale  Ν (%) 
 
I prefer to make a decision regarding a health issue: 
 
Alone without any help 40 (4.9%) 
By myself after taking into serious consideration my doctors opinion 572 (69.2%) 
Together with my doctor 166 (20.1%) 
I wish my doctor to make a decision after taking into consideration my 
opinion 
39 (4.7%) 
I wish my doctor to make a decision 6 (0.7%) 
 
 
Table IV. Univariate Logistic Regression Analysis for HBM dimensions related to  
                attitude towards vaccination  
 
  Univariate Analysis  
(attitude towards HPV Vaccination) 
 
HBM Variables OR (95% CI for Mean) P value 
Susceptibility For 6,49-7,30 .00 
 Against 4,77-5,60  
Severity For 5,54-6,39 NS 
 Against 5,69-6,54  
Benefits For 7,60-8,47 .00 
 Against 4,76-5,50  
Barriers For 3,99-4,99 .00 
 Against 7,76-8,77  
 
 
